PolarCool signs agreement with the Swiss Handball Association for the use of PolarCap®

The med-tec company PolarCool AB (publ) have signed an agreement with the Swiss Handball Association. The agreement implements that PolarCap® System will be provided to the Swiss Men’s National Handball Team throughout their upcoming 2024 European Handball Championships in Germany.

PolarCool develops the product PolarCap®, which alleviates the effects of concussions. The primary customers are sports clubs and facilities in ice hockey, rugby, football and handball, but also other sports with an increased risk of concussion.

PolarCool has recently achieved strong momentum by finalizing agreements in both rugby and ice hockey. Additionally, the company aims to strategically expand its reach into the progressive market of Handball, and the collaboration with the Swiss Handball Association marks another significant step forward within the market segment. The initial phase of this collaboration involves the implementation of PolarCap® during the men’s 2024 European Championship campaign.

PolarCool CEO Erik Andersson comments:

-The dialogue with the Swiss Handball Association has been very positive. The medical doctor for the men’s national handball team was clear early on that he wanted to provide PolarCap®. As head injuries in handball are known, our aim is that more teams and leagues will acknowledge PolarCap® as a treatment for concussion and its shown positive effects.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se 

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.